Pharmaceutical - Antibiotics and Infectious diseases

Filter

Popular Filters

1 to 25 of 234 results

FDA's anti-infective committee recommends Astellas' Cresemba

FDA's anti-infective committee recommends Astellas' Cresemba

23-01-2015

The US Food and Drug Administration’s Anti-Infective Drugs Advisory Committee has voted unanimously…

Antibiotics and Infectious diseasesAstellasCresembaPharmaceuticalRegulationUSA

ORCHID project aims to slash development time of tuberculosis drugs

ORCHID project aims to slash development time of tuberculosis drugs

14-01-2015

A collaborative project led by a scientist from UK pharma major GlaxoSmithKline has identified new compounds…

Antibiotics and Infectious diseasesGSKIsoniazidPharmaceuticalResearch

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

13-01-2015

Swiss pharma major Roche, Japanese pharma company Meiji Seika and private biotech company Fedora have…

Antibiotics and Infectious diseasesMeiji Seika PharmaOP0595PharmaceuticalResearchRoche

Russia’s Nanolek commissions plant for production of nano-based drugs

12-01-2015

Russia's Nanolek has officially commissioned a new facility for the production of drugs for the treatment…

Antibiotics and Infectious diseasesCardio-vascularNanolekOncologyPharmaceuticalProductionRussia

SinSa Labs signs license agreement for technology platform leading to new antibiotics

SinSa Labs signs license agreement for technology platform leading to new antibiotics

09-01-2015

Singapore-based SinSa Labs has signed a license agreement with Singapore Health Services and technology…

Antibiotics and Infectious diseasesDorzidinLicensingPharmaceuticalResearchSingaporeSinSa Labs

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

08-01-2015

Researchers at Northeastern University in Boston, MA, and NovoBiotic Pharmaceuticals have made a breakthrough…

Antibiotics and Infectious diseasesMicrobiologyNovoBiotic PharmaceuticalsPharmaceuticalResearchTeixobactin

BioCryst's Rapivab approved by FDA to treat influenza

BioCryst's Rapivab approved by FDA to treat influenza

23-12-2014

USA-based BioCryst Pharmaceuticals has received approval from the US Food and Drug Administration for…

Antibiotics and Infectious diseasesBioCryst PharmaceuticalsperamivirPharmaceuticalRegulationUSA

FDA approves new antibacterial drug Zerbaxa

20-12-2014

The US Food and Drug Administration has approved Cubist Pharmaceuticals’Zerbaxa (ceftolozane/tazobactam)…

Antibiotics and Infectious diseasesCubist PharmaceuticalsMerck & CoPharmaceuticalRegulationUSAZerbaxa

FDA approves Alcon’s Xtoro to treat swimmer’s ear

FDA approves Alcon’s Xtoro to treat swimmer’s ear

18-12-2014

The US Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used…

Acute otitis externaAlcon LaboratoriesAntibiotics and Infectious diseasesHealthNovartisPharmaceuticalRegulationUSAXtoro

Janssen commits $30 million to USAID agreement to fight antibiotic-resistant bacteria

Janssen commits $30 million to USAID agreement to fight antibiotic-resistant bacteria

12-12-2014

US health care giant Johnson & Johnson’s subsidiary Janssen has made an agreement with the United States…

Antibiotics and Infectious diseasesJanssenPharmaceuticalResearchUSA

Africa will be hardest hit region of anti-microbial resistance, warns report

Africa will be hardest hit region of anti-microbial resistance, warns report

11-12-2014

Low income countries are likely to suffer the greatest loss of population and economic output if anti-microbial…

Antibiotics and Infectious diseasesFinancialPharmaceuticalResearchRest of the WorldSub-Saharan Africa

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

09-12-2014

Effective malaria control has dramatically reduced the number of people dying from the disease since…

Anti-viralsAntibiotics and Infectious diseasesPharmaceuticalResearchRest of the World

FDA advisory panel backs Actavis’ ceftazidime-avibactam

06-12-2014

Ireland-headquartered generic drugs major Actavis says that the Anti-Infective Drugs Advisory Committee…

ActavisAntibiotics and Infectious diseasesAstraZenecaceftazidime-avibactamPharmaceuticalRegulationUSA

Urgent action needed to address Clostridium difficile infections in Europe

Urgent action needed to address Clostridium difficile infections in Europe

03-12-2014

Urgent action is needed to address the current issues relating to the management of health care-acquired…

Antibiotics and Infectious diseasesEuropeEuropean ParliamentPharmaceuticalPolitics

FDA approves Sanofi’s Priftin for latent TB

FDA approves Sanofi’s Priftin for latent TB

03-12-2014

French pharma major Sanofi says that the US Food and Drug Administration has approved Priftin (rifapentine),…

Antibiotics and Infectious diseasesPharmaceuticalPriftinRegulationSanofiUSA

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

27-11-2014

The Medicines for Malaria Venture has signed collaboration agreements with Cipla and Strides Arcolab,…

Antibiotics and Infectious diseasesCiplaIndiaPharmaceuticalResearchStrides Arcolab

Médecins Sans Frontières begins brincidofovir and favipiravir trials in Ebola treatment centers in West Africa

Médecins Sans Frontières begins brincidofovir and favipiravir trials in Ebola treatment centers in West Africa

14-11-2014

International medical humanitarian organization Médecins Sans Frontières (MSF) is to host clinical…

Anti-viralsAntibiotics and Infectious diseasesbrincidofovirfavipiravirPharmaceuticalResearchWest Africa

Polyphor’s POL7080 receives QIDP designation from the FDA

12-11-2014

Privately-held Swiss pharma firm Polyphor says that the US Food and Drug Administration has designated…

Antibiotics and Infectious diseasesPharmaceuticalPOL7080PolyphorRegulationRocheUSA

New Zealand proposal for sole supply of Remicade in DHB hospitals

New Zealand proposal for sole supply of Remicade in DHB hospitals

31-10-2014

Following a Request for Tender for infliximab issued on September 2, 2014 (RFT), New Zealand’s Pharmaceutical…

Anti-Arthritics/RheumaticsAntibiotics and Infectious diseasesceftaroline fosamilFinancialJanssen-CilagJohnson & JohnsonNew ZealandPharmaceuticalPricingRemicade

Safety trials under way for GSK and Canadian Public Health Agency's Ebola vaccines

Safety trials under way for GSK and Canadian Public Health Agency's Ebola vaccines

27-10-2014

Safety trials are currently under way in two of the most advanced Ebola candidates, and the World Health…

Antibiotics and Infectious diseasesGSKPharmaceuticalResearchUKUSA

EMA completes review of polymyxins and issues updated guidance

EMA completes review of polymyxins and issues updated guidance

24-10-2014

The European Medicines Agency has completed its review of polymyxin-based medicines and issued its recommendations…

Antibiotics and Infectious diseasesColistimethateEuropePharmaceuticalRegulation

New Zealand's PHARMAC funds four new medicines as part of major agreement with Novartis

New Zealand's PHARMAC funds four new medicines as part of major agreement with Novartis

20-10-2014

New Zealand's Pharmaceutical Managment Agency PHARMAC has agreed to fund four new medicines for which…

Antibiotics and Infectious diseasesCardio-vascularglycopyrroniumindacaterolNew ZealandNovartisOmalizumabPharmaceuticalRegulationRespiratory and PulmonaryTobramycin

1 to 25 of 234 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top